NuStar Energy LP
Change company Symbol lookup
Select an option...
NS NuStar Energy LP
DOCU DocuSign Inc
VHUB Vapor Hub International Inc
VMC Vulcan Materials Co
VLO Valero Energy Corp
VIAC ViacomCBS Inc
VFC VF Corp
VECO Veeco Instruments Inc
VALE Vale SA
V Visa Inc
Go

Energy : Oil, Gas & Consumable Fuels | Small Cap Value
Company profile

NuStar Energy L.P. is engaged in the transportation of petroleum products and anhydrous ammonia; the terminalling and storage of petroleum products, and the marketing of petroleum products. The Company's segments include pipeline, storage and fuels marketing. The pipeline segment consists of the transportation of refined petroleum products, crude oil and anhydrous ammonia. The storage segment consists of facilities that provide storage, handling and other services for petroleum products, crude oil, specialty chemicals and other liquids. The fuels marketing segment involve the purchase of crude oil, fuel oil, bunker fuel, fuel oil blending components and other refined products for resale. It conducts its operations through its subsidiaries, primarily NuStar Logistics, L.P. and NuStar Pipeline Operating Partnership L.P. It has approximately 10,000 miles of pipeline and 73 terminal and storage facilities that provide approximately 72 million barrels of storage capacity.

Price
Delayed
$18.19
Day's Change
-0.38 (-2.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.74
Day's Low
18.10
Volume
(Below Average)

Today's volume of 265,894 shares is on pace to be lower than NS's 10-day average volume of 447,379 shares.

265,894

EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Ocugen, Inc.

11:52 am ET June 11, 2021 (Newsfile) Print

New York, New York--(Newsfile Corp. - June 11, 2021) - Levi & Korsinsky notifies investors that it has commenced an investigation of Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN) concerning possible violations of federal securities laws.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7091/87327_15c557aa54a85a1a_001full.jpg



To view an enhanced version of this graphic, please visit:

https://orders.newsfilecorp.com/files/7091/87327_15c557aa54a85a1a_001full.jpg

On May 26, 2021, Ocugen announced its plan to submit an Emergency Use Authorization ("EUA") application for COVAXIN, a COVID-19 vaccine, to the U.S. Food & Drug Administration in June 2021.

On June 10, 2021, the Company said it would no longer pursue a EUA for Covaxin and would instead aim to file for a full U.S. approval of the shot.

On this news, the stock price plummeted and closed today at $6.69 per share, representing a 25.17% drop from yesterday's closing price of $9.31 per share. To obtain additional information, go to:

https://www.zlk.com/pslra-1/ocugen-inc-information-request-form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/87327

comtex tracking

COMTEX_388146173/2523/2021-06-11T11:52:36

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.